AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹268 Cr | ₹250 Cr | ₹246 Cr | ₹230 Cr | ₹208 Cr |
What is the latest Total Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹268 Cr |
| Mar2024 | ₹250 Cr |
| Mar2023 | ₹246 Cr |
| Mar2022 | ₹230 Cr |
| Mar2021 | ₹208 Cr |
How is Total Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹268 Cr | 7.50 | |
| Mar2024 | ₹250 Cr | 1.54 | |
| Mar2023 | ₹246 Cr | 6.82 | |
| Mar2022 | ₹230 Cr | 10.72 | |
| Mar2021 | ₹208 Cr | - | |
Compare Total Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹200.9 Cr | -3.8% | 2.1% | -30.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -3.8% |
2.1% |
-30.5% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses